8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Feb 8, 2024)

Filed February 8, 2024For Securities:DXCM

Summary

DexCom, Inc. (DXCM) has filed an 8-K report on February 8, 2024, to announce its financial results for the fourth quarter and full year ended December 31, 2023. The filing primarily consists of a press release (Exhibit 99.1) detailing these results and other relevant information. Investors should note that the information furnished in this Item 2.02 is not considered "filed" for legal liability purposes under Section 18 of the Exchange Act, nor is it automatically incorporated into future SEC filings unless specifically referenced. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release for the complete financial performance. This includes key metrics for both the recent quarter and the full fiscal year, providing a comprehensive update on the company's operational and financial condition. Investors are encouraged to review Exhibit 99.1 for the specific revenue, profit, and any forward-looking guidance provided by DexCom.

Key Highlights

  • 1DexCom (DXCM) released its Q4 and Full Year 2023 financial results via an 8-K filing on February 8, 2024.
  • 2The core of the filing is a press release (Exhibit 99.1) containing the company's operational and financial performance details.
  • 3Investors should refer to the press release for specific financial metrics, including revenue and profitability for the periods ended December 31, 2023.
  • 4The information provided in the 8-K's Item 2.02 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
  • 5The filing also includes the Cover Page Interactive Data File in Inline XBRL format.
  • 6This report serves as the official notification of DexCom's latest financial performance update.

Frequently Asked Questions

The specific financial results for the quarter and year ended December 31, 2023, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing.

The 8-K filing states that the press release contains 'certain other information' in addition to financial results. Investors should consult Exhibit 99.1 to determine if forward-looking guidance or projections were provided by DexCom.

Information 'furnished' under Item 2.02 is generally not subject to the same liability provisions as 'filed' information under Section 18 of the Securities Exchange Act of 1934. This means that while the information is made public, it does not carry the same legal accountability if it were later found to be inaccurate.